Logo Cellply

Resources

PUBLICATIONS

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy
Inter-Cell Networking Profiling Enables Comprehensive Characterization of Immune-Mediated Activity of Anti-CD38 Therapy through Ex-Vivo Analysis of Multiple Myeloma Patients
Ex-Vivo Drug Response Profiling for Precision Medicine Approaches in Acute Myeloid Leukemia with the Open Microwell Microfluidic Platform

Publication_Ex-Vivo Drug Response Profiling for Precision Medicine Approaches in Acute Myeloid Leukemia with the Open Microwell Microfluidic Platform_2016-12

ABSTRACTS

Abstract ESGCT_2024

BROCHURES

VivaCyte extended brochure – PS003

A comprehensive paper describing VivaCyte and all its potential to support research in the area of cell therapies.

PRODUCT SHEET | Document number: PS-003

VivaCyte – Technical specifications

Complete Spech Sheet of VivaCyte.

PRODUCT SHEET | Document number: PS-004

Brochure_PS-006 WF2_Rev24103

CellFit Services

TECHNICAL NOTE

TN-005_High throughput parallel screening of multiple Effector : Target (E:T) ratios for cell mediated cytotoxicity kinetic analysis using low sample volume

Learn how VivaCyte can generate multiple dose-response analyses in a single CC-Array plate, based on a cell-mediated cytotoxicity assay carried out at multiple E:T ratios

TECHNICAL NOTE | Document number: TN-005

TN-006_A novel method for comparing the potency of CAR-NK cells to support informed donor selection

Introducing a novel Unified Potency Score (UPS) to quantify the potency of cell therapy products with a single indicator, generated by single-cell killing and serial killing data

TECHNICAL NOTE | Document number: TN-006

TN-007_Characterization of NK cell donors for allogeneic cell therapy using single cell serial killing

Learn how a single-cell serial killing assay allows deep characterization of immune cell function and enables ranking of donors for allogeneic NK cell therapy

TECHNICAL NOTE | Document number: TN-007

TN-008_How single-cell multiparametric analysis enables in-depth understanding of functional heterogeneity and killer kinetics in CAR-T cell therapies

Learn how multiparametric analysis allows to define the potency of subpopulations of cells in a single assay through a combined single-cell analysis of cytotoxicity and phenotype carried out on each immune cell

TECHNICAL NOTE | Document number: TN-008